Chen Q - Search Results

1

Clinical significance of circPVT1 in patients with non-small cell lung cancer who received cisplatin combined with gemcitabine chemotherapy.

Lu H, Xie X, Chen Q, Cai S, Liu S, Bao C, Luo J, Kong J. Lu H, et al. Among authors: chen q. Tumori. 2021 Jun;107(3):204-208. doi: 10.1177/0300891620941940. Epub 2020 Jul 31. Tumori. 2021. PMID: 32734834

2

Clinical prognostic significance of serum high mobility group box-1 protein in patients with community-acquired pneumonia.

Lu H, Zeng N, Chen Q, Wu Y, Cai S, Li G, Li F, Kong J. Lu H, et al. Among authors: chen q. J Int Med Res. 2019 Mar;47(3):1232-1240. doi: 10.1177/0300060518819381. Epub 2019 Feb 7. J Int Med Res. 2019. PMID: 30732500 Free PMC article.

3

The miRNA-149-5p/MyD88 axis is responsible for ursolic acid-mediated attenuation of the stemness and chemoresistance of non-small cell lung cancer cells.

Chen Q, Luo J, Wu C, Lu H, Cai S, Bao C, Liu D, Kong J. Chen Q, et al. Environ Toxicol. 2020 May;35(5):561-569. doi: 10.1002/tox.22891. Epub 2019 Dec 19. Environ Toxicol. 2020. PMID: 31855318

4

Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells.

Lu H, Xie X, Wang K, Chen Q, Cai S, Liu D, Luo J, Kong J. Lu H, et al. Among authors: chen q. Mol Cell Biochem. 2020 Dec;475(1-2):63-77. doi: 10.1007/s11010-020-03860-1. Epub 2020 Aug 6. Mol Cell Biochem. 2020. PMID: 32767026

5

Osimertinib is an effective epidermal growth factor receptor-tyrosine kinase inhibitor choice for lung cancer with epidermal growth factor receptor exon 18-25 kinase domain duplication: report of two cases.

Zhang LD, Gao H, Qin SM, Zeng Q, Chen QF. Zhang LD, et al. Among authors: chen qf. Anticancer Drugs. 2022 Jan 1;33(1):e486-e490. doi: 10.1097/CAD.0000000000001148. Anticancer Drugs. 2022. PMID: 34261918

6

Impact of KMN network genes on progression and prognosis of non-small cell lung cancer.

Gao H, Pan QY, Wang YJ, Chen QF. Gao H, et al. Anticancer Drugs. 2022 Jan 1;33(1):e398-e408. doi: 10.1097/CAD.0000000000001220. Anticancer Drugs. 2022. PMID: 34419962

7

A case of lung adenocarcinoma with MET∆ex14 mutation regressed after preoperative treatment with savolitinib, and successfully underwent radical resection.

Yang F, Chen QF. Yang F, et al. Anticancer Drugs. 2023 Feb 1;34(2):302-305. doi: 10.1097/CAD.0000000000001417. Epub 2023 Nov 17. Anticancer Drugs. 2023. PMID: 36730552

8

Coexistence of a secondary STRN-ALK, EML4-ALK double-fusion variant in a lung adenocarcinoma patient with EGFR mutation: a case report.

Zeng Q, Gao H, Zhang L, Qin S, Gu Y, Chen Q. Zeng Q, et al. Among authors: chen q. Anticancer Drugs. 2021 Sep 1;32(8):890-893. doi: 10.1097/CAD.0000000000001094. Anticancer Drugs. 2021. PMID: 34232939

9

Influence of rs1746048 SNPs on clinical manifestations and incidence of acute myocardial infarction in Guangxi Han population.

Wang F, Wang W, Qin S, Chen Q, Huang Z, Huang D, Li T, Li J, Sun Z, Liu X, Zeng X, Ning Z, Liao Y. Wang F, et al. Among authors: chen q. Int J Clin Exp Pathol. 2019 Jan 1;12(1):282-294. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31933744 Free PMC article.

10

Potential therapeutic targets of the nuclear division cycle 80 (NDC80) complexes genes in lung adenocarcinoma.

Sun ZY, Wang W, Gao H, Chen QF. Sun ZY, et al. J Cancer. 2020 Mar 4;11(10):2921-2934. doi: 10.7150/jca.41834. eCollection 2020. J Cancer. 2020. PMID: 32226507 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36,981 results

Search Page

Filters